Sin conexión a internet: se muestra la versión guardada de la página.

Q32 Bio Inc

USUSD
← Al Screener

Q32 Bio Inc (US:QTTB) — Biotechnology: Pharmaceutical Preparations. Número de bolsas en las que cotizan las acciones de la empresa: 2. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.

Sobre la Empresa

Sitio Web
q32bio.com
Sector
Health Care · Biotechnology: Pharmaceutical Preparations
Sede Central
WALTHAM, United States
Consejero Delegado
Jodie Pope Morrison
Empleados
22
Acciones en Circulación
29.77 M a 2026-08-03
Capital Flotante
14.64 M
Capitalización Bursátil
248.28 M USD
Insiders
2.1%
Inversores Institucionales
80.73%
Industria (SIC)
Pharmaceutical Preparations
P/E
2.8
FCF
−33.5 M USD
Deuda
0 USD
caja neta
Resultados y FCF — para los 12 meses hasta 30.06.2026 (el último informe de la empresa).
Descripción

Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti–interleukin-7 receptor alpha antagonist monoclonal antibody which completed Phase 2a clinical trials, designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb – CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition and a range of other indications. The company was founded in 2017 and is based in Waltham, Massachusetts.

anuncio

Bolsas y Tickers

BolsaTickerMonedaPrecioTipo
US USA StocksQTTB principalUSD8.74 +4.80%acciones ordinarias
LSE London Stock Exchange0T6G IOBUSD8.83 +0.00%acciones ordinarias

Precio en 3 Meses

día alcista día bajistaPasa el cursor / toca un día — precios de apertura, cierre, máximo y mínimo

Principales Accionistas

TitularParticipaciónAccionesFecha del Informe
Orbimed Advisors LLC.13.87%4.13 M2026-06-30
Boxer Capital Management…10.58%3.15 M2026-06-30
Atlas Venture Life Scien…9.13%2.72 M2026-06-30
BVF Inc.7.89%2.35 M2026-06-30
RA Capital Management, L…7.84%2.33 M2026-06-30
Point72 Asset Management…3.94%1.17 M2026-06-30
Opaleye Management Inc.3.13%931 0002026-06-30
Logos Global Management…2.69%800 0002026-06-30
Summittx Capital, L.P.2.46%733 7742026-06-30
Vanguard Capital Managem…1.74%518 8032026-06-30
American Century ETF Tru…1.74%518 2522026-08-31
VANGUARD INDEX FUNDS-Van…1.31%389 1152026-06-30
MORRISON JODIE POPE (Chi…≈1.15%343 2592026-08-25
VIOLETTE SHELIA M (Offic…≈0.55%164 0482026-08-25
KALOWSKI LEE (President)≈0.47%138 4712026-08-25
VANGUARD INDEX FUNDS-Van…0.4%119 2692026-06-30
MANKE ISAAC (Director)≈0.18%53 5212026-06-30
Fidelity Concord Street…0.17%51 0152026-07-31
First TRT Exch-Trd Fd.-F…0.15%45 4112026-08-31
CAMPAGNA JASON (Officer)≈0.13%37 5002025-02-24
Bridgeway Funds, Inc.-Ul…0.12%34 6132026-06-30
iShares Trust-iShares Mi…0.1%29 2712026-08-31
American Century ETF Tru…0.08%22 6222026-08-31
Fidelity Concord Street…0.07%19 7922026-07-31
American Century ETF Tru…0.06%17 8582026-08-31
ORBIMED ADVISORS, L.L.C.…——2026-05-28
XU DIYONG (Director and…——2026-05-28